These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Evidence-Based Toxicology Collaboration (EBTC). Editorial. von Aulock S ALTEX; 2013; 30(1):1. PubMed ID: 23451363 [No Abstract] [Full Text] [Related]
3. Gender-based differences in endocrine and reproductive toxicity. Cummings AM; Stoker T; Kavlock RJ Environ Res; 2007 May; 104(1):96-107. PubMed ID: 17157289 [TBL] [Abstract][Full Text] [Related]
4. The integrated project ReProTect: a novel approach in reproductive toxicity hazard assessment. Hareng L; Pellizzer C; Bremer S; Schwarz M; Hartung T Reprod Toxicol; 2005; 20(3):441-52. PubMed ID: 15899576 [TBL] [Abstract][Full Text] [Related]
5. Implications of gender differences for human health risk assessment and toxicology. Vahter M; Gochfeld M; Casati B; Thiruchelvam M; Falk-Filippson A; Kavlock R; Marafante E; Cory-Slechta D Environ Res; 2007 May; 104(1):70-84. PubMed ID: 17098226 [TBL] [Abstract][Full Text] [Related]
8. Novel strategies for toxicological risk assessments. Roy A; Akbarsha MA ALTEX; 2014; 31(1):91-3. PubMed ID: 24448760 [No Abstract] [Full Text] [Related]
9. REACH testing requirements must not be driven by reproductive toxicity testing. Spielmann H; Vogel R Altern Lab Anim; 2006 Aug; 34(4):365-6. PubMed ID: 16945004 [No Abstract] [Full Text] [Related]
10. Reproductive health hazards in the pharmaceutical industry. Clement JD Occup Med; 1997; 12(1):131-43. PubMed ID: 9153058 [TBL] [Abstract][Full Text] [Related]
11. Assessment of reproductive toxicity under REACH. Aulmann W Regul Toxicol Pharmacol; 2012 Jul; 63(2):286-90. PubMed ID: 22475931 [TBL] [Abstract][Full Text] [Related]
12. Special issue: SBiRM: invited papers from MPI Research summit/symposium: Current trends in developmental and reproductive toxicology --August 21-23, 2011. Preface. Faqi AS Syst Biol Reprod Med; 2012 Feb; 58(1):1-2. PubMed ID: 22239075 [No Abstract] [Full Text] [Related]
13. Toxicology rethinks its central belief. Calabrese EJ; Baldwin LA Nature; 2003 Feb; 421(6924):691-2. PubMed ID: 12610596 [No Abstract] [Full Text] [Related]
14. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents). Brent RL Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191 [TBL] [Abstract][Full Text] [Related]
15. The use of the rat in developmental immunotoxicology studies. Chapin RE Hum Exp Toxicol; 2002; 21(9-10):521-3. PubMed ID: 12458910 [TBL] [Abstract][Full Text] [Related]
16. Fundamentals are still relevant in toxicology. Eaton DL; Greenlee WF Nature; 2002 May; 417(6885):117. PubMed ID: 12000934 [No Abstract] [Full Text] [Related]
17. The challenge of reproductive and developmental toxicology under REACH. Scialli AR Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093 [TBL] [Abstract][Full Text] [Related]
18. Animal testing and alternative approaches for the human health risk assessment under the proposed new European chemicals regulation. Höfer T; Gerner I; Gundert-Remy U; Liebsch M; Schulte A; Spielmann H; Vogel R; Wettig K Arch Toxicol; 2004 Oct; 78(10):549-64. PubMed ID: 15170526 [TBL] [Abstract][Full Text] [Related]
19. Introduction to special issue on developmental and reproductive toxicology in China. Daston GP Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):1. PubMed ID: 20166228 [No Abstract] [Full Text] [Related]
20. Alternatives to the use of animals in research, education and testing. Macharia Theuri S; Ngonyo J; Wangari Kagai M ALTEX; 2016; 33(2):183-5. PubMed ID: 27032089 [No Abstract] [Full Text] [Related] [Next] [New Search]